Hindustan Organic Chemicals (BSE 500449)₹59.67+4.25%Commodity Chemicals
In the Sep 2026 quarter (consolidated), Hindustan Organic Chemicals reported sales of ₹236 Cr, up 86.4% from Sep 2025, and net profit of ₹34.97 Cr. For the year to Mar 2026, sales were ₹575 Cr and net profit −₹13.01 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 187 | 183 | 59.20 | 175 | 165 | 137 | 165 | 126 | 147 | 136 | 96.33 | 236 |
| Expenses | 189 | 183 | 82.76 | 174 | 190 | 172 | 176 | 143 | 151 | 120 | 90.66 | 188 |
| Operating Profit | −2.99 | −0.99 | −23.92 | 0.00 | −25.91 | −36.90 | −12.95 | −16.94 | −3.99 | 16.94 | 4.98 | 46.85 |
| OPM % | −1.7% | −0.3% | −40.1% | 0.0% | −16.1% | −27.0% | −8.1% | −14.1% | −2.5% | 11.9% | 5.0% | 19.9% |
| Other Income | 4.01 | 7.01 | 5.01 | 5.01 | −35.07 | 552 | 13.02 | 5.01 | 5.01 | 4.01 | 4.01 | 5.01 |
| Interest | 18.05 | 17.04 | 16.06 | 18.06 | 18.05 | −10.02 | 5.02 | 5.01 | 5.01 | 5.01 | 5.01 | 6.02 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 1.01 |
| Profit before tax | −18.03 | −12.02 | −35.02 | −14.02 | −79.09 | 524 | −6.01 | −18.04 | −4.01 | 15.03 | 4.01 | 45.03 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | −7.1% | 0.0% | 21.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | −43.03 | 542 | 7.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −17.99 | −12.01 | −35.02 | −14.01 | −78.98 | 520 | −6.01 | −18.01 | −4.01 | 16.01 | 3.99 | 34.97 |
| EPS (Rs) | −2.66 | −1.78 | −5.28 | −2.04 | −11.77 | 77.49 | −0.95 | −2.71 | −0.59 | 2.35 | 0.58 | 5.21 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 143 | 177 | 276 | 504 | 326 | 408 | 435 | 633 | 706 | 538 | 575 | 616 |
| Expenses | 264 | 334 | 441 | 473 | 383 | 380 | 432 | 622 | 703 | 620 | 589 | 548 |
| Operating Profit | −121 | −159 | −166 | 27.89 | −57.84 | 26.89 | 0.99 | 5.98 | −0.99 | −85.77 | −17.94 | 64.78 |
| OPM % | −85.0% | −90.1% | −61.1% | 6.0% | −18.1% | 7.0% | 0.2% | 1.0% | −0.1% | −16.0% | −3.1% | 10.5% |
| Other Income | 15.02 | 6.01 | 63.07 | 117 | 21.03 | 21.04 | 34.07 | 6.01 | 18.04 | 527 | 26.03 | 18.04 |
| Interest | 69.20 | 98.23 | 78.25 | 68.24 | 58.20 | 54.12 | 66.20 | 67.23 | 70.17 | 43.09 | 20.05 | 21.05 |
| Depreciation | 10.02 | 9.02 | 6.02 | 3.01 | 3.01 | 3.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | 2.02 |
| Profit before tax | −185 | −259 | −187 | 73.08 | −98.08 | −8.01 | −32.04 | −55.04 | −54.07 | 395 | −14.03 | 60.06 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.0% | −7.1% | — |
| Exceptional items | 10.01 | 0.00 | 4.99 | 33.98 | 1.01 | 0.00 | 0.00 | −3.99 | 0.99 | 506 | 6.99 | 0.00 |
| Net Profit | −185 | −259 | −187 | 72.99 | −97.96 | −8.01 | −32.01 | −55.02 | −54.01 | 392 | −13.01 | 50.96 |
| EPS (Rs) | −26.85 | −38.43 | −27.80 | 10.80 | −14.35 | 0.39 | −4.42 | −7.96 | −8.14 | 58.40 | −1.91 | 7.55 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67.13 | 67.19 | 67.11 | 67.09 | 67.15 | 67.16 | 67.19 | 66.87 | 66.92 | 66.90 | 67.01 | 67.00 |
| Reserves | −934 | −1,121 | 52.00 | −33.02 | 43.97 | −50.06 | −36.03 | −72.23 | −118 | −119 | 976 | 963 |
| Borrowings | 700 | 705 | 605 | 610 | 607 | 522 | 519 | 1,224 | 1,284 | 1,360 | 206 | 285 |
| Other Liabilities | 457 | 581 | 1,098 | 1,013 | 833 | 837 | 891 | 257 | 241 | 263 | 310 | 228 |
| Total Liabilities | 291 | 233 | 1,821 | 1,658 | 1,552 | 1,376 | 1,442 | 1,475 | 1,475 | 1,572 | 1,559 | 1,543 |
| Fixed Assets | 137 | 125 | 1,686 | 154 | 170 | 174 | 136 | 155 | 165 | 225 | 226 | 231 |
| CWIP | 10.99 | 3.99 | 3.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.99 | 0.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 143 | 104 | 131 | 1,504 | 1,382 | 1,202 | 1,307 | 1,321 | 1,310 | 1,346 | 1,328 | 1,311 |
| Inventories | 60.89 | 45.89 | 56.84 | 65.91 | 55.88 | 54.89 | 57.84 | 79.88 | 52.89 | 71.88 | 58.88 | 49.93 |
| Trade receivables | 25.10 | 9.03 | 9.04 | 8.03 | 23.08 | 12.05 | 4.02 | 9.03 | 19.05 | 20.07 | 17.07 | 8.03 |
| Cash & equivalents | 13.01 | 5.01 | 5.01 | 109 | 70.06 | 104 | 148 | 157 | 198 | 254 | 254 | 250 |
| Total Assets | 291 | 233 | 1,821 | 1,658 | 1,552 | 1,376 | 1,442 | 1,475 | 1,475 | 1,572 | 1,559 | 1,543 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −116 | 45.99 | 59.01 | −451 | −160 | −81.01 | −50.02 | 9.99 | −12.99 | −65.92 | 631 | −69.97 |
| Cash from investing activity | 0.00 | −6.02 | 0.00 | 344 | 112 | 164 | 8.03 | 11.04 | 7.03 | 56.15 | 10.04 | 12.03 |
| Cash from financing activity | 104 | −48.05 | −59.04 | 179 | 3.01 | −90.05 | 52.03 | −32.03 | −10.01 | 6.01 | −643 | 58.07 |
| Net cash flow | −12.02 | −8.01 | 0.00 | 72.07 | −45.04 | −8.01 | 9.01 | −11.01 | −16.02 | −4.01 | −1.01 | 0.00 |
| Capex | 4.23 | 6.60 | 0.42 | 0.31 | 0.58 | 0.86 | 0.20 | 0.43 | 0.99 | 1.09 | 7.21 | 1.86 |
| Free cash flow | −116 | 39.87 | 58.74 | −109 | −52.82 | 74.66 | −48.84 | 9.97 | −13.94 | −66.78 | 621 | −71.78 |
| CFO / OP % | 90.0% | −38.0% | −37.0% | 270.0% | −573.0% | 139.0% | −185.0% | 1,182.0% | −202.0% | 6,570.0% | −733.0% | 401.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 52 | 23 | 20 | 12 | 18 | 15 | 4 | 8 | 12 | 11 | 12 | 6 |
| Inventory days | 207 | 229 | 318 | 175 | 73 | 94 | 102 | 110 | 43 | 52 | 51 | 43 |
| Days payable | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 | 14 |
| Cash conversion cycle | −146 | −481 | −604 | −291 | −43 | 43 | 76 | 60 | 21 | 13 | 21 | 36 |
| Working capital days | −743 | −1,310 | −2,728 | 331 | 236 | 80 | −14 | −133 | −158 | −198 | 484 | 443 |
| ROCE % | — | — | −91.0% | −17.0% | 16.0% | −7.0% | 9.0% | 4.0% | 1.0% | 1.0% | −5.0% | 0.0% |
For the Sep 2026 quarter, Hindustan Organic Chemicals reported sales of ₹236 Cr, up 86.4% year on year and net profit of ₹34.97 Cr. The operating margin was 19.9%.
Hindustan Organic Chemicals' sales for the year to Mar 2026 were ₹575 Cr; over the last twelve months they were ₹616 Cr.
Net profit for the year to Mar 2026 was −₹13.01 Cr, and ₹50.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹7.55.
Hindustan Organic Chemicals reported borrowings of ₹285 Cr at Mar 2026, against cash and equivalents of ₹250 Cr.
Cash from operations was −₹69.97 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹71.78 Cr.